It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2016
  5. Otsuka Pharmaceutical and IBM Japan to Set Up Joint Venture for Digital Health Solutions in Central Nervous System Field

June 13, 2016

Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical and IBM Japan to Set Up Joint Venture for Digital Health Solutions in Central Nervous System Field

On June 13 (Japan time), Otsuka Pharmaceutical and IBM Japan finalized an agreement to establish Otsuka Digital Health Co., Ltd. (Otsuka Digital Health), a joint venture independent of Otsuka's pharmaceutical business, in order to start a digital health solutions business for psychiatry in Japan.

Otsuka Digital Health will market MENTAT, which was developed based on Otsuka's knowledge and expertise in the central nervous system and on IBM's Watson-based technology. The company will integrate and analyze a large volume of data held by medical institutions. Solutions will be provided for medical issues such as improving the quality of treatment and sharing useful information among hospital medical staff.

Overview of Otsuka Digital Health Co., Ltd.

Establishment Date
June 17, 2016
Capital
267 million yen
CEO designate
Yasuki Shimizu
Head Office
2-9 Kanda Tsukasa-machi, Chiyoda-ku, Tokyo 101-8535, Japan
Business areas
IT solutions and consultation services: provision and management of a variety of data; computer system development
Major shareholders and stock ownership ratio
Otsuka Pharmaceutical Co., Ltd. (85%), IBM Japan (15%)

Information in this news release was current as of the original release date.

Latest Corporate News Releases

Most Recent Releases